|
ALKBH5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.50509999977622E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.79830000000592E-05 |
| Normal-vs-Stage2 |
9.65800000000128E-05 |
| Normal-vs-Stage3 |
1.121760E-01 |
| Normal-vs-Stage4 |
2.861300E-03 |
| Stage1-vs-Stage2 |
1.384980E-01 |
| Stage1-vs-Stage3 |
6.740400E-01 |
| Stage1-vs-Stage4 |
1.470240E-01 |
| Stage2-vs-Stage3 |
1.162380E-01 |
| Stage2-vs-Stage4 |
6.870000E-01 |
| Stage3-vs-Stage4 |
1.615000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05690000004899E-06 |
| Normal-vs-AfricanAmerican |
6.14919999999408E-05 |
| Normal-vs-Asian |
2.389400E-01 |
| Caucasian-vs-AfricanAmerican |
5.960400E-01 |
| Caucasian-vs-Asian |
7.600600E-01 |
| AfricanAmerican-vs-Asian |
8.891800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4221000000102E-06 |
| Normal-vs-Female |
2.424500E-04 |
| Male-vs-Female |
8.596200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.392400E-04 |
| Normal-vs-Extreme_Weight |
3.016500E-04 |
| Normal-vs-Obese |
4.038200E-03 |
| Normal-vs-Extreme_Obese |
4.680800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.553200E-01 |
| Normal_Weight-vs-Obese |
2.692000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.692000E-01 |
| Extreme_Weight-vs-Obese |
6.433400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.539400E-01 |
| Obese-vs-Extreme_Obese |
7.120400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.615600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.036600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.72879999602327E-08 |
| Normal-vs-Age(81-100Yrs) |
4.017200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.967000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.914450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.262200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.998060E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.624000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.471210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.840900E-03 |
| Normal-VS-Type2 PRCC |
2.439100E-04 |
| Normal-VS-KIRP CIMP |
1.482220E-02 |
| Normal-VS-Unclassified PRCC |
4.21660000000657E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.942400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.350200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.290500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.566400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.674800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.189000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.744300E-03 |
| Normal-vs-N1 |
5.142600E-03 |
| Normal-vs-N2 |
4.309200E-01 |
| N0-vs-N1 |
6.599800E-01 |
| N0-vs-N2 |
8.959200E-01 |
| N1-vs-N2 |
7.036800E-01 |
|
|
